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As the population ages, the incidence of age-related neurological diseases and cognitive decline increases. To
further understand disease-related changes in brain function it is advantageous to examine brain activity changes
in healthy aging rodent models to permit mechanistic investigation. Here, we examine the suitability, in rodents,
of using a novel, minimally invasive anaesthesia protocol in combination with a functional MRI protocol to assess
alterations in neuronal activity due to physiological aging. 11 Wistar Han female rats were studied at 7, 9, 12, 15
and 18 months of age. Under an intravenous infusion of propofol, animals underwent functional magnetic
resonance imaging (fMRI) and functional magnetic resonance spectroscopy (fMRS) with forepaw stimulation to
quantify neurotransmitter activity, and resting cerebral blood flow (CBF) quantification using arterial spin
labelling (ASL) to study changes in neurovascular coupling over time. Animals showed a significant decrease in
size of the active region with age (P < 0.05). fMRS results showed a significant decrease in glutamate change with
stimulation (ΔGlu) with age (P < 0.05), and ΔGlu became negative from 12 months onwards. Global CBF
remained constant for the duration of the study. This study shows age related changes in the blood oxygen level
dependent (BOLD) response in rodents that correlate with those seen in humans. The results also suggest that a
reduction in synaptic glutamate turnover with age may underlie the reduction in the BOLD response, while CBF is
preserved.1. Introduction
Functional MRI (fMRI) is a non-invasive imaging method ideally
suited to longitudinal studies and is an important tool in the study of
healthy aging and age-related neurological disease. In humans the hae-
modynamic response detected by fMRI becomes less efficient with age
(D’Esposito et al., 1999; Huettel et al., 2001), and many progressive
age-related diseases such as hypertension and Alzheimer’s disease are
characterised by a breakdown in neurovascular coupling (Stanimirovic, blood oxygen level dependent;
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Current preclinical fMRI methods are not optimised for longitudinal
studies (Crofts et al., 2019). In order to perform MRI on rodents, most
studies use anaesthesia to minimise movement and distress to the animal
(Tremoleda et al., 2012). Although MRI of awake animals is possible,
there are many practical challenges to overcome (King et al., 2005; Lahti
et al., 1999; Martin et al., 2013). Many previous fMRI studies use
injectable anaesthetics, such as urethane or alpha-chloralose, with toxic,
carcinogenic or harmful properties (Dijkhuizen et al., 2001; Kennerly
et al., 2005) and therefore can only be used in non-recovery studies
(Tremoleda et al., 2012). Inhaled anaesthetics, such as isoflurane or
halothane, suppress the BOLD signal and shift the balance between
capillary and arterial BOLD signal, masking long term changes in activity
and artificially increasing the effect of noise or small variations (Paaso-
nen et al., 2018; Schroeter et al., 2014; Tsurugizawa et al., 2016).
Medetomidine may be a viable candidate for use in preclinical longitu-
dinal studies, but the variable depth of anaesthesia can cause complica-
tions (Tremoleda et al., 2012; Weber et al., 2006). Propofol, an injectable
anaesthetic common in veterinary practice is used here. Propofol dem-
onstrates a less pronounced effect on CBF, BOLD signal or the haemo-
dynamic response function when compared to other anaesthetics (Griffin
et al., 2010; Kelly et al., 2010; Paasonen et al., 2018; Schroeter et al.,
2014; Tremoleda et al., 2012; Van Zijl et al., 2012). Propofol is also
known to be rapidly metabolised and removed from the body, and has
previously been shown to have no cumulative effects from repeated use,
making it suitable for long term studies (Tremoleda et al., 2012). While
propofol has been shown to have adverse effects on the blood brain
barrier in juvenile mice (Sharma et al., 2014), studies of aged rats have
shown no adverse effects of propofol on the blood brain barrier (Hu et al.,
2014), and so this is not thought to be a risk in adult animals. In animals
anaesthetised with propofol, the haemodynamic response function has
also been shown to more closely match that of awake animals than other
anaesthetics (Schlegel et al., 2015). This has also been shown in mice
anaesthetised with a fentanyl/isoflurane mixture, with a similar signal
amplitude to animals recieving propofol (Sharp et al., 2015), suggesting
that Fentanyl may be an alternative to propofol for longitudinal studies.
The main disadvantages of Fentanyl are the possibility of prolonged re-
covery time (>4 h) and possibility of hypotension, which may pose a
welfare risk in older animals (Tremoleda et al., 2012).
Changes in the human brain with aging have been well characterised
with task-based and resting-state fMRI. The most notable change in task-
based BOLD signal with aging is a significant reduction in the number of
active voxels, 40–50% lower than observed in young subjects (Huettel
et al., 2001; Kannurpati et al., 2010; West et al., 2019). Between-subject
variability is greater in an aged cohort than a young cohort, possibly due
to the cumulative effects of lifestyle factors over time (D’Esposito et al.,
1999; Kannupati et al., 2010). This reduction in the size of the activated
region may be due to a combination of vascular and neuronal changes
and their contribution to the overall BOLD signal change may vary
depending on the region of interest. When vascular changes are consid-
ered, reduced BOLD signal in motor regions is found to be largely
attributable to vascular alterations, while in cognitive tasks BOLD signal
reduction is mainly attributable to neuronal loss (Kannurpati et al.,
2010). This illustrates an important limitation of BOLD fMRI that should
be accounted for – while changes in activity can be imaged, other ex-
periments are needed to determine the relative contributions of vascular
and neuronal factors and the processes behind these changes. Under-
standing the causal relationship between vascular and neuronal changes
with age is important in an ageing population in order to better treat
age-related cognitive decline, target risk factors for neurodegenerative
disease, and monitor rehabilitation in patients suffering from age-related
brain injury. Understanding changes with healthy aging in preclinical
models is also important, in order to improve on models of age-related
disease.
In order to understand the neuronal factors behind the BOLD signal, a
non-invasive method of quantifying neuronal activity is required.2Electrophysiology methods are invasive and are therefore not practical
for longitudinal studies due to their impact on animal welfare. A method
that has previously been suggested to give a non-invasive measurement
of neuronal activity is functional MR spectroscopy (fMRS). Obtaining two
spectra, with and without stimulation, and subtracting the two, the dif-
ference in relative concentrations of the neurotransmitter glutamate can
be detected and used to infer neuronal activity in the region (Gussew
et al., 2010). This method is limited in spatial resolution, measuring a
voxel several millimetres wide rather than the sub-millimetre resolution
provided by preclinical fMRI, however this may be useful when paired
with fMRI in studies of a single, known region of interest (Stanley and
Raz, 2018). In this study, we used fMRI to explore age-related changes in
somatosensory cortex activity in response to forepaw stimulation. The
stimulus design used, which applies a current of approximately 2.3 mA,
has been previously shown to only activate somatosensory fibres, and not
pain related fibres, while providing a robust BOLD and CBF signal under
propofol anaesthesia (Griffin et al., 2010). Understanding age-related
changes in healthy animals using fMRI is important in improving the
current understanding of age-related cognitive decline and age-related
pathologies. Additional fMRI methods can improve the understanding
of how neuronal and vascular components contribute to what is observed
with BOLD fMRI.
2. Materials and methods
2.1. Animals
This study was conducted in accordance with the UK Animals (Sci-
entific Procedures) Act, 1986 and following institutional ethical approval
by the University of Leicester Animal and Welfare Ethical Review Body.
All experiments are reported in accordance with the Animal research
reporting of in vivo experiments (ARRIVE) guidelines (Kilkenny et al.,
2010). A total of 11 female rats (Wistar Han, code CRL:WI(Han), Charles
River Laboratories) were used in the current study; all animals completed
the study. Rats aged 3 months on arrival were group housed in two
groups of four animals, and one group of three animals, in double decker
cages (floor area 1862 cm2, height 38 cm, Techniplast, UK) and given
daily access to a playpen for 2–6 h. Animals were fed PMI 5LF2 diet (Lab
Supply, Fort Worth, Texas, USA) ad libitum and mains water that had
been UV treated in house (Severn Trent, UK). Animals were first accli-
matised to single level playpens in groups of 3/4 for one week, followed
by two weeks of mixing up to 8 animals from two different cages
together, then mixing all animals into one playpen. At 12 months of age,
the playpen was replaced with a three-storey chinchilla cage kept in a
ventilator cabinet, maintained at room temperature, with an isolated air
supply and red glass doors to block external light sources. Preventing
outside air and external light prevents animals from seeing or smelling
humans while in the playpen, with the intention of promoting more
natural behaviour without anxiety from potential threats.
2.2. Experimental schedule
Bench experiments were performed on animals at 5 months old to test
the anaesthesia protocol and identify the correct dose rate. The protocol
described below was performed in order to test the initial dose rates of
7.5 mg/kg bolus followed by 42 mg/kg/hr infusion of propofol (Griffin
et al., 2010), without MRI scanning. When this did not induce a sufficient
depth of anaesthesia in initial tests, with animals displaying motion after
isoflurane was discontinued, animals were returned to isoflurane before
increasing the dose rate. Dose rates were increased in 10% increments
until a dose rate of 9 mg/kg bolus followed by 54 mg/kg/hr infusion was
identified as the lowest dose required to maintain anaesthesia, defined as
the animal showing no motion or change in breathing rate once iso-
flurane had been discontinued, and all animals remained stable using this
dose.
Animals were weighed prior to all MRI scans, and weighed daily for
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thesia. MRI scans were undertaken at the following time points; 7, 9, 12,
15 and 18 months. At 18 months old, immediately following the final
MRI scan, animals were humanely killed while under propofol anaes-
thesia. 6 animals were sacrificed using intravenous pentobarbitone. 5
animals were sacrificed using intraperitoneal pentobarbitone, and
transcardially perfused with formaldehyde solution.
2.3. Anaesthesia protocol
Animals were anaesthetised with isoflurane (5% induction; 2–3%
maintenance) in 100% oxygen. Tail vein cannulation was performed
before transferring the animals to the MRI bed. A bolus of 9 mg/kg/min
propofol was administered for 1 min using a syringe driver (Harvard
Apparatus, Cambridge, Massachusetts, USA) and the isoflurane was
gradually reduced to 0%, with animals still breathing 100% oxygen.
Respiration was monitored using a respiration pillow (Small Animal In-
struments Inc. Stony Brook, New York, USA), temperature monitored
using a rectal probe and maintained using a fan heater activated when
measured temperature dropped below 37 C (Small Animal Instruments
Inc. Stony Brook, New York, USA), and heart rate and blood oxygen
saturation monitored using a pulse oximeter (Starr Life Sciences, Oak-
mont, Pennsylvania, USA). Copper electrodes were inserted subcutane-
ously into the dorsal surface of the right forepaw between digits 1–2 and
2–3 (Hyder et al., 1994). Three minutes after the bolus ended, a
continuous infusion of propofol was given at 54 mg/kg/hr for the
duration of the scan. Following the scan, animals were allowed to recover
in a separate cage. Analgesic cream (EMLA cream, AstraZeneca, UK) was
applied to the forepaw where electrodes had been removed, and animals
were provided with water and wet food pellets to prevent dehydration
after anaesthesia. Animals were awake within 15 min following removal
of anaesthesia, and moving freely within 30 min, at which point they
were returned to their home cage.
2.4. MRI protocol
MRI scans were performed on a 9.4T Small Animal MRI scanner
(Agilent Technologies), using a 72 mm RF volume transmit coil and a 2-
channel surface receive coil (Rapid Biomedical, Rimpar, Germany).
Coronal scout images were used to locate bregma, and three 1.5 mm
slices were selected with bregma in the middle slice. A shimming voxel
with dimensions 10 x 9  4.5 mm was positioned to cover the centre of
all three slices, excluding non-brain tissue or tissue outside the slices of
interest. Fast, automatic shimming technique by mapping along pro-
jections (FASTMAP, Gruetter, 1992) was used to shim these slices to a
50% water linewidth between 20 and 35Hz. Rats were switched from
breathing oxygen to room air, pumped at 2 L/min using an air pump
(Wiz-Air, Clarke Tools, Dunstable, UK). fMRI was performed for 9 min
using a gradient echo EPI sequence (TR¼ 250ms, TE¼ 22 ms, kzero¼ 8,
shots ¼ 2, data matrix ¼ 128 x 128). The forepaw was stimulated at 10
mV, 10Hz, pulse width 1μs, with a block design of 60s off, 30s on.
Following this, a 4 x 4  4 mm voxel was positioned over the left so-
matosensory cortex at bregma, andmanual shimming was performed to a
50% water linewidth of <25Hz. A localisation by adiabatic selective
refocusing (LASER, Slotboom et al., 1991) MRS sequence (TR¼ 2000ms,
TE ¼ 14.54 ms, 270 arrayed averages) was used to perform fMRS over 9
min, using the same forepaw stimulation paradigm used for fMRI. For
analysis, the first 30 s of each “off” block were discarded to allow time for
metabolites to return to baseline levels. Oxygen saturation was main-
tained above 80% during functional experiments (Tremoleda et al.,
2012). Animals were switched back to 100% oxygen after all functional
scans were complete, in order to minimise any welfare risks extended use
of anaesthesia and room air. After being returned to 100% oxygen, a
time-of-flight (TOF) angiography scan was performed in order to position
the labelling plane for ASL, followed by a T2 weighted structural scan.
Using the TOF angiography image, the carotid artery was located and a3labelling plane placed with a gap of 17mm from bregma. 6 min of
continuous arterial spin labelling (CASL) was performed on a single 1.5
mm slice placed over bregma (TI ¼ 1500 ms, TR¼ 2500 ms, TE¼ 10 ms,
shots ¼ 1, kzero ¼ 16, data matrix ¼ 128 x 128).
2.5. Data analysis
A fMRI analysis pipeline was developed using FSL (www.fmrib.ox.ac.
uk/fsl; Smith et al., 2004). MCFLIRT (Jenkinson et al., 2002), rBET (a
modified version of BET to account for differences in the shape of the rat
brain compared to the human brain, Smith, 2002;Wood et al., 2013), and
FAST (Zhang et al., 2001) were used for motion correction, brain
extraction and bias field correction respectively. Independent component
analysis for artefact removal, using MELODIC (Beckmann and Smith,
2004) were performed prior to time-series analysis in FEAT (Woolrich
et al., 2001) to visualise the BOLD response. Cluster analysis was per-
formed on the first-level FEAT outputs to determine number of active
voxels, maximum % signal change within the cluster, and mean % signal
change across the cluster. In each scan, time to peak was calculated for
each of the six stimulus blocks and averaged, with a temporal resolution
of 0.5 s (Baumann et al., 2010).
fMRS spectra were separated into “off” and “on” blocks and averaged
using the MATLAB FID-A toolkit (Simpson et al., 2017). The two spectra
were analysed using the TARQUIN MRS analysis package (www.tarq
uin.sourceforge.net) to determine relative concentrations of glutamate.
Metabolite concentrations from “off” blocks were subtracted from “on”
blocks to determine the difference in glutamate concentration, and the
difference in glutamate change (ΔGlu) was averaged across subjects.
“Off” blocks were also used to quantify NAA and Inositol, used as markers
of neuronal viability and inflammation, respectively.
Control and tag ASL images were first concentrated into a single
image of two volumes. The Oxford ASL toolkit for FSL was used to sub-
tract the tag image from the control image to create a difference image.
FSLmaths was used to apply a modified Bloch equation (Williams et al.,
1992) to the data in order to quantify CBF in absolute units. CBF map
images were given an upper threshold of 5 to remove large outliers. This
was determined based on the histogram of voxel intensities, in which
some scans displayed a small number of single voxels with large in-
tensities between 5 and 80 having a large influence on the mean.
Non-zero mean and standard deviation CBF were calculated using
FSLstats.
Statistical analysis was performed in Graphpad Prism (Version 8,
California, USA). Data are shown as mean  standard deviation (SD).
Changes over time were analysed using a repeated measures ANOVA,
fitting a mixed effects model to account for missing values, and the cri-
terion for statistical significance was P < 0.05. Where statistically sig-
nificant differences were found, post-hoc testing to compare individual
time points was performed using the Tukey-Kramer multiple compari-
sons test.
3. Results
3.1. Animal body weight and physiological monitoring
Body weight was found to significantly increase with age (Repeated
measures ANOVA, F ¼ 14.19, P < 0.0001), from 253  20.26 g at 7
months old to 310  24.61 g at 18 months, and remained within the
expected weight range for healthy Wistar Han rats (Fig. 1). Post-hoc
comparisons showed significant differences when comparing 7 months
vs 9 months (P¼ 0.0012), 7 vs 12 months (P¼ 0.012), 7 vs 15 months (P
¼ 0.0002), 7 vs 18 months (P ¼ 0.0001), 9 vs 15 months (P ¼ 0.0196), 9
vs 18 months (P ¼ 0.0004), 12 vs 15 months (P ¼ 0.0047), 12 vs 18
months (P¼ 0.0004), and 15 vs 18 months (P¼ 0.012). During scanning,
while breathing room air, oxygen saturation remained above 80%, which
has been previously defined as safe (Tremoleda et al., 2012). In 7 month
old animals, Oxygen saturation (Fig. 2A) was found to decrease from
Fig. 1. Individual rat weights at 7, 9, 12, 15 and 18 months (n ¼ 11).
Fig. 2. Oxygen saturation (A), Breathing rate (B) at the start and end of the
period on room air, and Temperature (C) at the start and end of scanning, in 7
months old and 18 months old animals (*P ¼ 0.05, ***P ¼ 0.001). Data is
displayed as mean  SD, n ¼ 8 and 7 respectively.
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the end of the period on room air, approximately 35 min (paired t-test, P4¼ 0.0002). However, in 18-month-old animals, oxygen saturation did not
significantly change from 92.83  4.89% in this time (Paired t-test, P ¼
0.0820). The breathing rate (Fig. 2B) while on room air also significantly
increased between the start and end of this period in 7 month old rats,
from 57.6  6.18 bpm to 65.4  8.04 bpm (paired t-test, P ¼ 0.0011),
however at 18 months, breathing rate did not significantly change from
54.71  6.55 bpm (paired t-test, P ¼ 0.1267). In 7 month old animals,
temperature (Fig. 2C) did not change over time from 37.2  0.47 C
(paired t-test, P ¼ 0.3629), however in 18 month old animals, tempera-
ture did significantly decrease during scans from 37.43  0.377 C to
36.63  0.46 C (paired t-test, P ¼ 0.0224).
3.2. Functional MRI
First-level analysis of BOLD fMRI data was performed in FEAT (Fig. 3)
and was used to quantify three aspects of the BOLD signal: number of
active voxels in S1FL, maximum % signal change in S1FL, and mean %
signal change in S1FL (Fig. 4). The number of active voxels was found to
significantly decrease with age (F (4, 27) ¼ 3.727, P ¼ 0.0153), with the
number decreasing from 399.5  356.8 at 7 months to 76.7  37.0 at 18
months old. Post-hoc testing found that there was a significant decrease
in the number of active voxels between the ages of 9 months (532.8 
570.3) and 15 months (114.7  46.91 m P ¼ 0.0367), and between 9
months and 18 months (76.7  37, P ¼ 0.0286). Standard deviation was
also shown to significantly decrease with age (Brown-Forsythe test, P ¼
0.0001). No significant difference was found in the maximum BOLD
signal change (F (4, 27) ¼ 0.1963, P ¼ 0.9381) or mean BOLD signal
change (F (4, 36) ¼ 1.422, P ¼ 0.2465) with age. Time-to-peak of the
BOLD signal was not found to significantly change with age (F (4, 27) ¼
2.210, P ¼ 0.0946, Fig. 5).
3.3. Functional MRS
The change in glutamate signal between off and on blocks (ΔGlu)
decreased significantly (F (4, 37) ¼ 4.018, P ¼ 0.0083) from 7 months
(73.4  103.6AU) to 18 months (1.08  1.19AU). Post-hoc testing
showed significant differences between 7 and 9 months (P ¼ 0.0447), 7
and 12 months (P ¼ 0.0162) and 7 and 15 months (P ¼ 0.009). From 12
months onwards, the glutamate signal change became negative, showing
an overall decrease in glutamate with activation (Fig. 6). NAA and
Inositol were also quantified (Fig. 7). Quantification of NAA displayed a
significant decrease (F (4, 27) ¼ 5.267, P ¼ 0.0025) in NAA from 36.50
 28.46AU at 7 months to 8.41  14.40AU at 18 months, with post-hoc
testing showing significant decreases between 7 months and 9 months (P
¼ 0.0076), 12 months (P ¼ 0.0083), 15 months (P ¼ 0.0029) and 18
months (P ¼ 0.048). Inositol was found to significantly decrease (F
(4,41) ¼ 1.68, P ¼ 0.0417) from 118.53  168.3AU at 7 months to 21.7
 58.1AU at 18months. 7 months and 15months (8.63 15.54AU) were
found to be significantly different in post-hoc testing (P ¼ 0.036).
3.4. Arterial spin labelling
Mean CBF across the slice did not change significantly between 7 and
18 months (F (4, 39) ¼ 1.438, P ¼ 0.2398), with low variability between
subjects (Fig. 8). Mean CBF at all time points was within a standard de-
viation of the expected value of 2.33ml/g/min observed in some previous
rodent experiments (Thomas et al., 2006).
4. Discussion
This study investigated changes in the BOLD signal, glutamate turn-
over and CBF with age in healthy rats using fMRI. Propofol was deter-
mined to be a suitable anaesthetic for longitudinal studies, causing no
detrimental effects to animal health and allowing detection of a strong
BOLD signal compared to observations using other anaesthetics (Schro-
eter et al., 2014). The stimulus paradigm allowed for detection of a strong
Fig. 3. Example images displaying S1FL activation in a representative rat at 7
months (A), 9 months (B), 12 months (C), 15 months (D) and 18 months. All
analysis was performed with a z threshold of 2.3 and cluster P threshold of 0.01.
Fig. 4. Effect of age on various aspects of the BOLD signal including the
maximum BOLD signal change in S1FL (A), the mean BOLD signal change of all
active voxels in S1FL (B), and the number of active voxels in S1FL (C). There was
a significant decrease in the number of active voxels with age (*P ¼ 0.05, be-
tween various times points). Data is displayed as mean  SD, n ¼ 8, 8, 8, 10, and
7 at 7, 9, 12, 15 and 18 months respectively.
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from the somatosensory stimulus, which does represent a limitation in
this method due to the possibility of motion artefacts. The anaesthetic
regime was well tolerated, with young animals showing a small decrease
in oxygen saturation over time during scanning. Aged animals did not
show a change in oxygen saturation during scanning, and all animals
maintained oxygen saturation above the safe limit of 80% (Tremoleda
et al., 2012). The size of the BOLD signal in the somatosensory cortex5decreased with age. fMRS showed a reduction in ΔGlu (glutamate during
stimulation – glutamate during rest) from 9 months onwards, with ΔGlu
becoming negative at 12 months old. ASL showed that resting CBF
remained constant for the duration of the study.
Here we report, for the first time, a decrease in the BOLD signal
during aging in rodents, which is consistent with human task-based fMRI
studies comparing young and aged groups, where the active region is
significantly reduced in size during motor tasks (Ances et al., 2009;
Huettel et al., 2001). The maximum and mean signal change remained
constant over all time points, and was consistently located in the centre of
the ROI, which is consistent with human studies where the BOLD signal
amplitude remains consistent in healthy aged subjects while the spatial
extent of the BOLD response is reduced (D’Esposito et al., 1999; Huettel
et al., 2001). Time-to-peak BOLD signal also remained constant at all
time points. While the reduction in size of the active region is consistent
with human studies, the reduction in variability between subjects with
age is not consistent with human studies (D’Esposito et al., 1999). Aged
human subjects show a greater variability in task-related BOLD signal
than young subjects (Kannurpati et al., 2010). Our data shows a reduc-
tion in variability between 12 and 18 months. In healthy volunteers,
there is uncontrolled variability in lifestyle factors and medical history,
whereas in our study, all animals, as is standard in preclinical studies,
experience the same highly controlled environment. Careful control of
lifestyle factors in this manner provides an excellent platform for future
treatment studies involving longitudinal fMRI (and other analyses).
While these results show similarities to observations in humans, they
do differ from observations in aged rats using optical image spectroscopy,
in which the haemodynamic response is measured using visible light
through a cranial window. With this method, aged rats (40 months) were
shown to display a larger active region in response to forepaw stimula-
tion than 4 or 24-month-old animals (Dubeau et al., 2011a). This could
be due to variation between groups, as a longitudinal study design was
not used. Alternatively, this could be due to differences between fMRI
and optical imaging. The BOLD signal and neurovascular signals detected
by optical imaging show high spatial correlation (Kennerly et al., 2005,
2012). However, the higher temporal resolution of optical imaging
Fig. 5. (A) Bar graph showing time to peak of BOLD signal at all time points. Data is displayed as mean  SD, n ¼ 8, 8, 8, 10, and 7 at 7, 9, 12, 15 and 18 months
respectively. (B–F) Average time series plots of BOLD signal at each time point, taken from the voxel with the highest z statistic. n ¼ 8, 8, 8, 10, and 7 at 7, 9, 12, 15
and 18 months respectively.
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optical imaging is more sensitive to an effect of aging that could not be
detected by fMRI.
Reduction in size of an active regionmay be due to synaptic plasticity,
neuronal death, reduction of neurovascular signalling, or reduced
vascular reactivity (Girouard and Iadecola, 2006). In normal learning and
development, or during recovery following ischaemic stroke, task-related
activity may shrink over time as connections are formed and become
more efficient (Penhue and Doyon, 2005). While this is unlikely in an6aging group of animals, animals in our study were provided novel stimuli
as part of the animals’ enrichment, which is thought to be beneficial for
somatosensory cortex function. Animal welfare is also an important
concern in longitudinal studies, and animals’ health over their lifetime
can have a major impact on study outcomes. For this reason, access to an
enriched environment providing more space, sensory enrichment and
socialisation than allowed by standard rat housing was provided in
accordance with previously identified requirements (Hutchinson et al.,
2005). Neuronal death, reduced neuronal activity, reduced
Fig. 6. Effect of age on glutamate change in S1FL with forepaw stimulation.
There was a significant decrease in the glutamate signal change with increasing
age (*P ¼ 0.05, between various times points). Data is displayed as mean  SD,
n ¼ 8, 10, 9, 11, and 4 at 7, 9, 12, 15 and 18 months respectively.
Fig. 8. The effect of age on resting CBF at bregma. There were no significant
differences in resting CBF at bregma at any of the time points measured. Data is
displayed as mean  SD, n ¼ 11 at all time points apart from n ¼ 10 at
18 months.
A. Crofts et al. NeuroImage 218 (2020) 116976neurovascular signalling and reduced neurovascular activity are all ele-
ments of age-related changes to the brain, with varying effects depending
on overall health (Girouard and Iadecola, 2006). Thus, the reduction in
size of the active region is likely an effect of healthy ageing, while the low
variability is likely due to the beneficial effects of the enrichment pro-
tocol. Future studies could take into account other effects on the fMRI
analysis. For example, in human studies, grey matter volume has been
shown to decrease with age, which could affect the BOLD signal.
Modelling the difference in grey vs white matter may be used to
compensate for this by calculating partial volume effects. However, this
requires longer scan times to optimise contrast in structural scans (Dukart
and Berolino, 2014), which was not practical at this stage due to the need
to minimise scan time. A limitation of BOLD fMRI is that the BOLD signal
is not a direct measure of neuronal activity. Impairment of neurovascular
coupling or changes in vascular reactivity can confound interpretation of
the BOLD signal. For this reason, a more direct measure of neuronal ac-
tivity can be beneficial. Glutamate is the most common neurotransmitter
in the brain (Walls et al., 2015), and so direct quantification of glutamate
turnover may complement BOLD fMRI data when investigating neuro-
vascular coupling. MRS is the least invasive method of measuring
neurotransmitter levels in vivo, and though there are limitations with
respect to spatial and temporal resolution, this method has previously
been applied to quantify task- or stimulus-based changes in glutamate
and lactate (Gussew et al., 2010; Stanley and Raz, 2018).
Here, we describe age-related changes in glutamate levels becoming
negative from 12 months onwards. The changes observed in glutamate
were seen earlier than changes observed in the BOLD signal. Human
studies using MRS have shown a decrease in overall glutamateFig. 7. Effect of age on intensity of NAA (A) and Inositol (B) levels with age in the s
increasing age (*P ¼ 0.05, between various times points). Data is displayed as mean
7concentration at a relatively young age, with one study showing a
reduction of 5 mmol/L between 20 and 55, and one study showing a
similar change between 18 and 32 (Hadel et al., 2013; Marsman et al.,
2013). The changes observed here with functional MRS may be due to
decreasing efficiency of glutamate turnover mechanisms with age.
Glutamate is normally stored in vesicles and released with activation. As
glutamate is released, increased glutamate production occurs to refill the
vesicles and glutamate is recycled with sustained activity through the
glutamine-glutamate cycle (Walls et al., 2015). If this cycle is impaired
with age, and glutamate production does not exceed or keep up with
glutamate release, this may bemeasured as a net decrease in glutamate. If
this is the case, it can also explain the reduction in BOLD signal observed
with age. Glutamatergic receptors on astrocytes may be an important
mediator of neurovascular coupling (MacVicar and Newman, 2015), and
reduced glutamate turnover would lead to reduced glutamate diffusion
outside the synaptic cleft. It is important to consider other mechanisms of
neurovascular coupling however, as there is conflicting evidence
regarding the role of metabotropic glutamate receptor 5 (mGluR5) on
astrocytes in rats (Calcinaghi et al., 2011), and the presence of mGluR5 in
the brains of adult mice (Sun et al., 2013). The range of metabolites
detectable by MRS is more limited than other methods, such as PET, and
so alternative, more invasive methods may be needed to study other
neurovascular signalling pathways. Additionally, due to the low SNR of
fMRS at the scan time used in this study, caution must be exercised in
interpreting the findings. Further studies using longer scan times, or
alternative MRS techniques to improve sensitivity or SNR are required to
confirm this hypothesis. While the LASER sequence allows for a short TE,
improving sensitivity to glutamate, techniques such as PRESS offer anomatosensory cortex. Both NAA and Inositol levels significantly decreased with
 SD, n ¼ 8, 10, 9, 11, and 4 at 7, 9, 12, 15 and 18 months respectively.
A. Crofts et al. NeuroImage 218 (2020) 116976improved SNR at the cost of a longer TE, which may be beneficial in the
shorter acquisition times required for a stimulus-based experiment (Zhu
and Barker, 2011). MEGA-PRESS (Mescher et al., 1998) or Carbon-13
spectroscopy (Lai et al., 2017) may also be useful, as sequences selec-
tive to glutamate can be designed, however these come at the cost of a
reduced resolution or requirement for radiolabelled glutamate, respec-
tively. Improving the sensitivity of the fMRS method this way is impor-
tant for this method to be of value in understanding glutamate turnover
in future studies, and to better understand the change in glutamate
concentration seen in humans.
We also measured changes in the levels of the metabolites, NAA and
inositol, as they are correlated with age-related cognitive decline in
humans. NAA is reported to be a neuronal marker and an indicator of
neuronal integrity as others have reported a correlation between NAA
and neuronal density in patients with Alzheimer’s disease (Cheng et al.,
2002). With respect to aging others have demonstrated a decrease in
NAA levels in human studies (Boumezbeur et al., 2009; Lim and Spiel-
man, 1997; Schmitz et al., 2018) which is consistent with the age-related
decline in NAA we observed here and may be indicative of reduced
neuronal density or neuronal function. However, changes in NAA levels
in humans may be regionally dependent (Eylers et al., 2016) which we
did not assess here, and further studies could correlate changes in such
levels with alterations in cognitive function. Inositol, or myo-inositol, is
considered to be a putative glial marker (Martin, 2007) and higher levels
are seen in patients with, for example, Alzheimer’s disease or fronto-
temporal dementia, which might be expected in conditions associated
with higher gliosis (Ernst et al., 1997). However, it is still not clear what
changes in absolute levels of inositol represent – it may be that changes,
as reported here, reflect changes in glial metabolism (Marajanska et al.,
2017). The decrease in NAA and glutamate turnover after 7 months may
suggest that this is the point where rodent brains mature from young
adulthood to middle age, as some human studies have shown a decrease
in NAA between at this time as formation of new pathways slows down
(Cichoka and Beres, 2018), however, further study in humans and ro-
dents is needed to fully understand such changes.
ASL, as used here, allows imaging of cerebral perfusion. No changes
were seen in mean CBF across the lifespan of the animals studied here,
and values were similar to those reported in previous rodent studies
(Thomas et al., 2006), however some studies do report a lower value
(Wegener et al., 2007) which may be due to variation between strains.
This would suggest that mechanisms of cerebral autoregulation remained
intact in these animals. Human studies vary in whether aging affects
resting perfusion, showing either no change in CBF (Meltzer et al., 2000)
or a decrease in CBF with age (Tarumi and Zhang, 2018). In this study,
the consistent level of perfusion taken with the change in glutamate
suggests that changes in the BOLD signal are caused by neuronal factors
rather than vascular factors.
To our knowledge, this study for the first time shows age-related
changes in stimulus-induced BOLD signal in a longitudinal study of
rats. Through use of a novel anaesthesia protocol, which overcomes the
limitations of other anaesthetics, a large active region was detected in the
somatosensory cortex of young rats, which decreased in size over the
animals’ lifetime. This is consistent with the difference in BOLD signal
between young and old human volunteers. In contrast to human studies,
the aged animals showed very low between-subject variability, which
may be due to the animal cohort all experiencing the same living envi-
ronment, while lifestyles in human volunteers are variable. A further
study with a larger cohort may allow the age at which changes to the
BOLD signal begin to be identified. There are somemethodological issues
in the current study to consider in terms of the short TR used, which,
combined with limitations in shimming an adequate volume, did limit
scans to three slices over the region of interest without loss of image
quality. While this allowed for a high temporal resolution and a large
number of repeats, whilst keeping scan time to 9 min, the limited field of
view did prevent image registration to high-resolution T2 weighted im-
ages or to a standard space. Because of this, it was necessary to analyse8images at first level, then number of active voxels and signal intensity
recorded, and then group level comparisons were performed manually.
Whole-brain fMRI would facilitate registration of images to a standard
structural space, thus allowing voxel-wise group level analysis to be
performed. As we have demonstrated the utility of the anaesthesia pro-
tocol, future studies can incorporate longer scan times, and maintain
animals on room air for longer, and so whole brain images can be ob-
tained either through improved shimming or a longer TR and additional
stimulus blocks. fMRS also suffered from low SNR due to the need for a
short scan time, as the total length of the protocol was kept to approxi-
mately 1 h to minimise risk from the novel anaesthetic protocol, which
may be improved on in future studies. The issue of variable number of
subjects at different time points can also be addressed. In this study,
technical difficulties with scanner hardware and monitoring equipment
did mean that some animals had to be recovered before completing the
protocol, and additional scans to rectify this were avoided for welfare
purposes. As no harmful effects of repeated scanning were observed here,
future studies can use additional scans where necessary to ensure the
number of animals studied is consistent at all time points. High vari-
ability at early time points is also a limitation of this study, and although
use of a repeated measures statistical analysis may account for this in
part, future studies must address this in the methodology. This may be a
physiological factor in young adult rats, in which case a larger cohort
would be necessary. Alternatively, if this is a result of hardware vari-
ability, further refinement of shimming protocols may be beneficial to
minimise variation between scanning sessions.
To compare findings in animals and findings in humans, it is also
important to consider the effect of anaesthetic. All anaesthetic agents
cause a reduction in BOLD signal intensity and electrophysiological ac-
tivity (Lahti et al., 1999; Schlegel et al., 2015). However, whether this
effect is consistent across age groups, or becomes more or less pro-
nounced with age has not yet been studied. To study this in a longitudinal
experiment would require lengthy acclimatisation procedures to ensure
animals remain still and are minimally distressed by the scanner, and
knowledge of whether this acclimatisation is disrupted as animals age
(Crofts et al., 2020). Until this can be made feasible, potential changes in
the effect of anaesthetic with age are one limitation of these studies.
Wistar Han rats have been previously used as a model for aging
(Korhonen et al., 1997; Badowska-Szalewska et al., 2017), as these ani-
mals show low tumour incidence and lower weight gain than other
strains (Weber, 2017). The 2 year survival rate of Wistar Hans rats is 63%
(Charles River, 2011), and so for welfare purposes, 18 months was
determined to be a humane end point for this study. To equate this to
human age, one month of aging in rats can be roughly equated to three
human years (Sengupta, 2013), equating 18 months in rodents to 54
years of age in humans. Spectroscopy studies in humans have shown
age-related changes in glutamate concentration before middle age (Hadel
et al., 2013; Marsman et al., 2013), and changes in BOLD signal in
humans have been shown between groups with mean ages of 24 and 58
(Kannurpati et al., 2010). Thus, 18 months can be considered old enough
to display equivalent age-related changes in rats, while young enough to
minimise the risk of illness. 7 months was determined to be an appro-
priate starting point, equating to 21 years of age in humans, and previous
studies suggest that 5–6months is the age at which rats can be considered
socially mature (Sengupta, 2012). As this strain has been shown to
remain healthy with the enrichment described, and exhibited no adverse
effects from anaesthesia, future studies may extend the end point further,
to observe changes in rats in the equivalent of 60s, 70s or 80s in human
age. Studies into the effect of different levels of enrichment would also be
beneficial, both to animal welfare and to understanding how lifestyle
affects brain ageing. For this study only female rats were used, to mini-
mise any welfare risks due to fighting in group housed males, or mixing
groups of males in the playpen. It is also important that future studies
address differences between male and female rats, however this may
need modifications to the enrichment protocol to minimise fighting be-
tween males in playpens.
A. Crofts et al. NeuroImage 218 (2020) 116976To further refine these methods, additionalMRI sequences, additional
analysis methods, or post-mortem examinations beyond the scope of this
study can be added to the protocol in future work. This may include ASL
fMRI, in order to quantify age effects on stimulus-induced CBF changes
with age, rather than using the more abstract % change in BOLD signal.
Additionally, refinements to sequences could include longer angiography
scans in order to quantify structural properties of the vasculature, as
opposed to using a short angiography scan to aid in labelling plane
positioning for ASL. Parameters to structural images could also be refined
in order to give better grey/white matter contrast for calculating partial
volume effects (Dukart and Berolino, 2014). As fMRI sequences are
further refined, multiparametric studies can also be used to perform
biophysical modelling in order to better understand how each parameter
reflects changes in neurovascular coupling, which has previously been
used in optical image spectroscopy studies (Dubeau et al., 2011b).
Ex-vivo studies, such as electrophysiology or immunostaining, would
also be beneficial to understand the cellular and molecular components
of the mechanisms described.
Combining results from all MRI techniques, the reduction in size of
the active BOLD region, shift to a negative glutamate change, while CBF
and NAA levels remained constant, offers an explanation of how neuro-
vascular coupling may change with age. It is possible that the reduced
glutamate turnover is the cause of the observed reduction in size of the
BOLD signal, without significant neuronal death or impairment of cere-
bral autoregulation. These methods have application in the study of
neurodegenerative, neurological and vascular diseases and may enable
longitudinal preclinical studies, which are relevant for progressive dis-
eases such as stroke or Alzheimer’s disease to improve the translational
relevance of such preclinical models (Sauter et al., 2002; Dijkhuizen
et al., 2003; Hu et al., 2004; Sanganahalli et al., 2013). In addition, the
combination of a multi-parametric fMRI protocol may enable factors
influencing neurovascular coupling in response to aging and neurode-
generative conditions to be further explored. These methods also repre-
sent a refinement to animal welfare, in that animals can be kept healthy
for 18 months, and animal numbers can also be reduced, which will
benefit animal research as a whole.
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